Scientific Advisory Board

Daniel Oberg PhD – Board Member

Dr. Daniel Öberg has a PhD in medical virology with a specialisation in anticancer gene therapy. He completed five years of postdoctoral oncolytic research at the Institute of Cancer, London. He has since been working for four years as an assistant professor at Uppsala University.
Daniel has developed and experimented with the vector Ixovex. He has lectured at M.Sc. level ion various topics including general and specific virology, gene therapy, ”virus and cancer” and ”virus and immune defence”.

Professor Kevin Harrington is Joint Head of the Division of Radiotherapy and Imaging at the Institute of Cancer Research. He is a specialist in Head and Neck cancer and in melanoma. He is a Fellow of the Royal College of Physicians and the Royal College of Radiologists.
Prof Harrington has translated numerous therapies into clinical trial, particularly in the field of head-and-neck cancer providing Ixogen with invaluable experience.

Professor Alan Melcher moved to The Institute of Cancer Research, London, as Professor of Translational Immunology and Honorary Consultant Oncologist at The Royal Marsden NHS Foundation Trust. He combines a clinical practice in head and neck cancer and melanoma research focused on oncolytic viruses and immunotherapy for the treatment of cancer.
He Holds a PhD at the Imperial Cancer Research Fund (now Cancer Research UK) and prior he was a post-doctoral research fellow at the Mayo Clinic, Minnesota. He became Professor of Clinical Oncology and Biotherapy in Leeds in 2007.
Professor Alan Melcher graduated in medicine from the University of Oxford in 1989, and trained in Clinical Oncology (Radiotherapy and Chemotherapy) in Cardiff, London and Leeds.

Martin completed his specialist training in Medical Oncology in 2008 and was appointed as a UCL Clinical Senior Lecturer and UCH Consultant in Medical Oncology in 2009. He has been running a research-based practice and has been principal / chief investigator for more than 20 early and late phase clinical trials while working in cancer care and training in Medical Oncology at the Oxford Radcliffe and Royal Marsden NHS Trusts.
Martin is involved in the management of patients with both lung and head and neck cancers and has a particular interest in the cancer biology that leads to the development of both lung and head and neck cancers.
Martin graduated from the University of Newcastle upon Tyne and gained general medical experience in New Zealand, Australia and the United Kingdom, becoming a member of the Royal College of Physicians (UK) in 2000. He holds a PhD at the Institute for Cancer Research, London and was awarded the EORTC-PAMM Young Investigator Award in 2004.